Immunopathogenesis of severe pneumonia in children with emphasis on CD4+ T cells, Tim-3 and cytokine-mediated immune dysregulation - Report - MDSpire

Immunopathogenesis of severe pneumonia in children with emphasis on CD4+ T cells, Tim-3 and cytokine-mediated immune dysregulation

  • By

  • Fang Cao

  • Qi Zhang

  • Lunan Yan

  • July 16, 2026

Share

Clinical Report: Pathophysiology of Severe Pneumonia in Pediatric Patients

Background

Severe pneumonia is a leading cause of hospitalization and mortality in children, particularly those under five years old. The immune response, rather than just pathogen burden, significantly influences disease severity and outcomes.

Data Highlights

No numerical or trial data were provided in the source material.

Key Findings

  • CD4+ T cells play a central role in coordinating immune responses in pneumonia.
  • Tim-3 serves as an immune checkpoint that may indicate various states of T-cell dysfunction.
  • Cytokines such as IL-6, IL-8, IL-1β, and TNF-α contribute to inflammation and systemic injury in severe pneumonia.
  • Children with severe pneumonia may exhibit reduced and functionally constrained CD4+ T-cell responses.
  • The interplay between innate and adaptive immune responses is critical in determining disease outcomes.

Clinical Implications

Clinicians should consider the role of immune dysregulation in pediatric pneumonia when assessing disease severity and treatment responses. Monitoring CD4+ T-cell function and cytokine levels may provide insights into patient management.

Conclusion

The pathophysiology of severe pneumonia in children involves complex interactions between immune cells and cytokines, necessitating further research to elucidate these mechanisms.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Profound immune suppression and exhaustion characterize refractory mycoplasma pneumoniae pneumonia in children
  2. Infection, 2025 -- Current Insights on the Treatment and Management of Pediatric Pneumonia: An In-Depth Review
  3. Frontiers in Pediatrics, 2026 -- Insights into the mechanism of intestinal flora imbalance and immune disorder in co-morbidity of pneumonia and diarrhea in children
  4. Frontiers in Immunology — The role and mechanisms of multiple immunoregulatory cells in pulmonary tuberculosis
  5. IDSA/PIDS 2026 Guidelines for the Management of Community-Acquired Pneumonia (CAP) in Infants and Children Older Than 3 Months of Age
  6. WHO Guideline on management of pneumonia and diarrhoea in children up to 10 years of age
  7. NICE Recommendations for Pneumonia: diagnosis and management
  8. Inflammatory cytokines as biomarkers for disease severity in pediatric viral pneumonia: a systematic review and meta-analysis - PMC
  9. Frontiers | Diagnostic and prognostic utility of salivary and serum procalcitonin, interleukin-6, and interleukin-10 in pediatric pneumonia: a prospective case-control study
  10. Serum cytokine levels in children with community-acquired pneumonia caused by different respiratory pathogens | Italian Journal of Pediatrics | Springer Nature Link
  11. Differences in immune function and cytokine levels among children in different age groups with severe community-acquired pneumonia | Scientific Reports
  12. TIM-3 on myeloid cells promotes pulmonary inflammation through increased production of galectin-3 | Communications Biology

Original Source(s)

Related Content